PlainPharmaWatch

CMS Open Payments · Program Year 2024

Vesalio, Inc.

Vesalio, Inc. reported $16,449,628.00 across General Payments, Research, and Ownership to 18 physicians and teaching hospitals across 38 transactions.

See the rankings → How this is sourced
$16.4M
All-tracks total
38
Transactions
18
Recipients
+$28.5K
General Payments vs PY2023

Vesalio, Inc. reported $16,449,628.00 across all CMS Open Payments tracks (General + Research + Ownership) to 18 physicians and teaching hospitals in Program Year 2024 - ranking #115 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $36,000.00, averaging $913.9K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer vesalio-inc Vesalio, Inc.

$16.4M · #115/1,925 · 0.1% industry · PY2024

  • TOT $16.4M
  • RANK #115
  • SHARE 0.1%
  • TXN 38
  • RCP 18
  • CAT 2
  • GEN $36.0K
  • ΔGEN +$28.5K
  • TOP1 25.0%
  • PY 2024

Volume peers

Nearest volume peer: Aveo Pharmaceuticals, Inc. ($16.4M)

GastroGPO, LLC$16.6MAlkermes, Inc.$16.6MGenmab U.S., Inc.$16.5MVesalio, Inc. (this)$16.4MAveo Pharmaceuticals, Inc.$16.4M
All-tracks payment totals near Vesalio, Inc. (CMS Open Payments PY2024)

Vesalio, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Vesalio, Inc.'s CMS-reported General Payments increased by $28.5K (+380.0%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2023: VESALIO, INC.PY2024: Vesalio, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$7.5KPY2024$36.0K
PY2023
$7,500.00
PY2024
$36,000.00

What the Data Shows for Vesalio, Inc.

Vesalio, Inc. ranks #115 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, representing 0.1% of all industry payments reported nationwide for the year. The underlying total is $16,449,628.00 across 38 transactions to 18 physicians and teaching hospitals - $432.9K per transaction and $913.9K per recipient on average.

Of the 2 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $23.0K across 9 transactions, 63.9% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 2 types of general payments, Vesalio, Inc.'s largest category was "Compensation for Services Other Than Consulting" at $23.0K - 63.9% of General Payments.

How Vesalio, Inc. divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$23.0K2. Consulting Fee$13.0K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $23.0K 9
Consulting Fee $13.0K 9

Recipient Concentration in General Payments

The five largest recipient relationships account for $28,000.00 (77.8%) of $36,000.00 in this company's General Payments records across 10 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Vesalio, Inc.

The five named recipients with the highest reported General Payments from this company

Ameer Hassan$9.0KNick Abedi$8.0KNaiem Nassiri$4.5KShahid Nimjee$3.5KHalim Yammine$3.0K
  1. 1

    Ameer Hassan

    $9,000.00 across 2 reported transactions

  2. 2

    Nick Abedi

    $8,000.00 across 4 reported transactions

  3. 3

    Naiem Nassiri

    $4,500.00 across 3 reported transactions

  4. 4

    Shahid Nimjee

    $3,500.00 across 2 reported transactions

  5. 5

    Halim Yammine

    $3,000.00 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Vesalio, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Vesalio, Inc..

Joimax, Inc.

HHI 1571

Intelivation Technologies, LLC

HHI 1566

Align Ophthalmics LLC

HHI 1585

Surmodics, Inc.

HHI 1594

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Vesalio, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Vesalio, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.